Recent research has indicated that cancer patients infected with respiratory viruses exhibit a positive antitumor response. This group develops a bioorthogonal optimized nonpathogenic-recombinant virus for targeted therapy of solid tumors.
- Wenchang Peng
- Yajing Du
- Xingcai Zhang